Generics - Rest of the World

Filter

Current filters:

Rest of the World

Popular Filters

126 to 150 of 1334 results

Australian government urged to hold the line on IP protection

Australian government urged to hold the line on IP protection

11-12-2013

The Generic Medicines Industry of Australia (GMiA) is renewing its call on the Australian government…

Asia-PacificAustraliaGenericsPatents

Teva vice chairman Moshe Many to leave post for 'personal reasons'

Teva vice chairman Moshe Many to leave post for 'personal reasons'

11-12-2013

Israel’s Teva Pharmaceutical Industries announced yesterday that the vice chairman of its board of…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Russian government to change mechanism for setting prices for essential drugs

Russian government to change mechanism for setting prices for essential drugs

10-12-2013

The Russian government is considering changing the mechanism of setting prices for essential drugs in…

Eastern EuropeGenericsPharmaceuticalPricingRussia

Actavis sells 51% stake in Russian subsidiary

Actavis sells 51% stake in Russian subsidiary

10-12-2013

Leading global generics drugmaker Actavis says that it sold its 51% stake in the Russian drug company…

ActavisEastern EuropeFarmekoGenericsMergers & AcquisitionsRussiaZio-Zdorovye

Low level of “potentially problematic” patent settlements in EU pharma sector

Low level of “potentially problematic” patent settlements in EU pharma sector

09-12-2013

The European Commission's report on patent settlement agreements, also referred to as “pay-for-delay”…

EuropeFinancialGenericsPatentsPharmaceutical

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

African experts discuss need for better regulation of medicine

05-12-2013

In most African countries, pharmaceutical drugs are poorly regulated or not regulated at all, posing…

PharmaceuticalRegulationRest of the World

AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex

04-12-2013

Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

03-12-2013

South African conglomerate Bidvest, acting on behalf of a consortium including CIH, says it has offered…

Adcock IngramBiovest InternationalCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

03-12-2013

UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

Mixed views on Grattan Institute report on drug price cuts impact in Australia

Mixed views on Grattan Institute report on drug price cuts impact in Australia

03-12-2013

The Grattan Institute has published an updated report on Australia's drug pricing, which has been applauded…

Asia-PacificAustraliaGenericsPoliticsPricing

Polpharma manufacturing division assimilates Sanfarm in Nowa Dęba

30-11-2013

Sanfarm, a company operating in the Tarnobrzeg Economic Zone in Poland, has become part of leading Polish…

Eastern EuropeGenericsMergers & AcquisitionsPolpharmaProductionSanfarm

Phased-in approach to implementing EU Falsified Medicines Directive recommended; report

29-11-2013

Addressing the fight against counterfeiting, in connection with the Falsified Medicines Directive, the…

EuropeGenericsMarkets & MarketingRegulation

One in five South African health care centers experience ARV stock shortages

29-11-2013

South Africa’s Treatment Action Campaign (TAC) has warned that the country’s HIV treatment program…

Anti-viralsHealthcarePharmaceuticalProductionRest of the WorldSouth Africa

KKR acquires $200 million stake in India’s Gland Pharma

KKR acquires $200 million stake in India’s Gland Pharma

29-11-2013

Indian injectable generic firm Gland Pharma says it has reached an agreement under which Kohlberg Kravis…

Asia-PacificGenericsGland PharmaMergers & Acquisitions

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

28-11-2013

The Superior Court of Justice in Brazil recently annulled marketing approval for a sub-standard biosimilar…

BiosimilarsDoxelibGenericsLegalLibra LaboratoryOncologyRegulationSanofiSouth AmericaTaxotere

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers

26-11-2013

Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

Germany’s Merck invests in further research partnerships in Israel

Germany’s Merck invests in further research partnerships in Israel

26-11-2013

German pharma and chemicals firm Merck KGaA says it is increasingly counting on partnerships with Israeli…

BiotechnologyChanBioFinancialMerck KGaAMetabomedNeurologicalOncologyResearchRest of the World

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

CleveXel Pharma and Dynamix to develop oral treatment for RA

25-11-2013

CleveXel Pharma has entered into a partnering agreement with venture-backed Israeli biopharmaceutical…

Anti-Arthritics/RheumaticsCleveXel PharmaDynamix PharmaceuticalsEuropeLicensingPharmaceuticalResearchRest of the World

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

126 to 150 of 1334 results

Company Spotlight

Fibrotech

Fibrotech

Back to top